课题基金 / 基金详情

The regulation mechanism of cartilage destruction m osteoarthritis

The regulation mechanism of cartilage destruction m osteoarthritis
骨关节炎软骨破坏的调控机制
批准号:
14571386
负责人:
MATSUMOTO Tomoko
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

MATSUMOTO Tomoko的其他基金

相似基金

相关文献

中文摘要
翻译
软骨基质合成与降解的失衡导致关节软骨的破坏。为了了解骨关节炎中软骨破坏的调节机制,我们检测了胰岛素样生长因子(IGF)-I、地塞米松和mdomethacin对软骨组织分解代谢因子白细胞介素(IL)-1β作用的影响。我们进行了软骨细胞的单层或三维培养。在加入IL-1 β和IGF-1、地塞米松或吲哚美辛的情况下,用ELISA法测定培养液中IL-6和基质金属蛋白酶(MMP)-3、-9、-13的浓度。提取细胞总RNA,RT PCR检测细胞中聚集蛋白聚糖、Ⅱ型胶原、IL-6和MMP-3、9、13 mRNA的表达。IL-1 β在蛋白和mRNA水平上增加IL-6和MMPs的表达。IL-1 β的这种作用可被地塞米松和吲哚美辛所抑制,但不被IGF-1所抑制。这些结果表明,不同的机制可能存在于软骨破坏的调节。
英文摘要
Imbalances between synthesis and degradation of cartilage matrix lead the destruction of articular cartilage. To know the regulation mechanism of cartilage destruction in osteoarthritis, we have examined the effects of insulin-like growth factor (IGF)-I, dexamethasone, and mdomethacin on the action of interleukin (IL)-1β, which is the catabolic factor for cartilage tissue. We performed monolayer or three dimensional culture of chondrocytes. After adding the IL-I β with or without IGF-I, dexamethasone or indomethacin, the concentration of IL-6 and matrix metalloptroteinase (MMP)-3,-9,-13 in the culture medium was measured by ELISA. Further, total RNA was extracted from the cell layer, and the expression of aggrecan, collagen II, IL-6, and MMP-3,9,13 mRNA was measured by RT PCR.IGF-I induced the expression of aggrecan and collagen II mRNA both in the presence or absence of IL-β. IL-I β increased the expression of IL-6 and MMPs in the protein and mRNA levels. These effects of IL-Iβ was inhibited by dexamethasone and indomethacin but not by IGF-I. These results suggest that different mechanism may exist in the regulation of cartilage destruction.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
Matsumoto, T. et al.: "Inappropriate serum levels of IGF-I and IGPBP-3 in patients with rheumatoid arthritis"Rheumatology (Oxford). 41. 352-353 (2002)
Matsumoto, T. 等人:“类风湿性关节炎患者中 IGF-I 和 IGPBP-3 的血清水平不适当”《风湿病学》(牛津)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iioka T, et al.: "P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart 1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain."J Bone Miner Res. 18. 1419-1429 (2003)
Iioka T 等人:“P300/CBP 通过乙酰化与同源结构域相邻的保守赖氨酸残基,充当软骨同源蛋白-1 (Cart 1)(配对样同源蛋白)的共激活剂。”J Bone Miner Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsukazaki T et al.: "Functional domains of paired-like homeoprotein Cart1 and the relationship between dimerzation and transcription activity."Gene Cells. 7. 1135-1147 (2002)
Tsukazaki T 等人:“配对样同源蛋白 Cart1 的功能域以及二聚化与转录活性之间的关系。”基因细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsumoto T, et al.: "Transient osteoporosis of the Talus followed by migration to the tibia."Modem Rheumatology. 30. 371-375 (2003)
Matsumoto T 等人:“距骨短暂骨质疏松症,随后迁移至胫骨。”现代风湿病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    Pathology and treatment for osteoarthritis-efficient use of endogenous insulin-like growth factor-1
    • 批准号:
      17591582
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      MATSUMOTO Tomoko
    • 依托单位:
    The role of IGF-I and IGF-binding proteins in osteoarthritis
    • 批准号:
      12671424
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      MATSUMOTO Tomoko
    • 依托单位:
    Regulation mechanism of nsulin-like growth factor-binding proteins producion in osteoarthritis.
    • 批准号:
      09671503
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      1997
    • 负责人:
      MATSUMOTO Tomoko
    • 依托单位:
    Signal transduction of TGF-b in rat articular chondrocytes
    • 批准号:
      07671598
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1995
    • 负责人:
      MATSUMOTO Tomoko
    • 依托单位:
    海外基金